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Abstract
Background: The association between fish consumption and risk of bladder cancer has not been established yet.
The results from epidemiological studies are inconsistent.
Methods: We conducted a meta-analysis of cohort and case-control studies on the relationship between fish
intake and bladder cancer. We quantified associations with bladder cancer using meta-analysis of relative risk
associated to the highest versus the lowest category of fish intake using random effect models. Heterogeneity
among studies was examined using Q and I
2 statistics. Publication bias was assessed using the Begg’s funnel plot.
Results: Five cohort and 9 case-control studies were eligible for inclusion. The combined relative risk showed that
fish consumption was negatively, but not significantly, associated with a decreased risk of bladder cancer (relative
risk, 0.86; 95% confidence interval, 0.61-1.12). In subgroup analyses, there was no evidence that study design,
geographical region, case sample size, or exposure assessment substantially influenced the estimate of effects.
Conclusion: The overall current literature on fish consumption and the risk of bladder cancer suggested no
association. Because of the limited number of studies, further well-designed prospective studies are needed to
explore the effect of fish on bladder cancer.
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1. Background
Bladder cancer is the second most common urologic
malignancy and the seventh most common cancer in men.
It has been estimated that 386,300 patients are newly diag-
nosed with bladder cancer worldwide in 2008, and
approximately 150,200 patients were expected to die of it
[1]. Depending on its stage and grade, bladder cancer may
be treated with surgery, radiation therapy, chemotherapy,
or immunotherapy. Because bladder cancer has the high-
est lifetime treatment cost of any cancer, and direct expo-
sure to carcinogens is implicated in bladder cancer
development and many potentially protective compounds
are concentrated in urine, making it an ideal target for
preventive therapies [2].
Smoking, occupational exposure, and chronic infec-
tions with schistosoma are the most established risk fac-
tors for bladder cancer. At present, evidence on dietary
factors is also accumulating. Fish plays an important role
in the usual diet worldwide and is an ideal source of n-3
polyunsaturated fatty acids, which may lower cancer risk
by suppressing mutations, inhibiting cellular prolifera-
tion, and inducing cell apoptosis [3-5]. A report by the
World Cancer Research Fund and the American Institute
for Cancer Research on the relationship between diet and
cancer concluded, based on a comprehensive review of
epidemiologic studies, that fish consumption may possi-
bly protect against cancers of the colon, rectum, and
ovary [6]. Less attention, however, has been paid to the
role of fish consumption on bladder cancer risk. Several
epidemiological studies have examined the association
between fish intake and the risk of bladder cancer; the
majority of results are null, which could possibly be attri-
butable to lack of statistical power in individual studies.
Thus, we conducted a meta-analysis of all published stu-
dies to evaluate the relationship between fish consump-
tion and bladder cancer.
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2.1 Search strategy
We identified studies by a literature search of the
PubMed databases up to January 2011 with the following
key words: “fish,”“ meat,” or “diet” combined with “blad-
der cancer,”“ urothelial cancer,” or “urinary tract cancer.”
In addition, we reviewed the reference lists from all rele-
vant articles to identify additional studies. All searches
were conducted independently by two authors. The
results were compared, and any questions or discrepan-
cies were resolved through iteration and consensus.
2.2 Study selection
Following criteria were used to identify relevant studies
for the meta-analysis. First, they had to be case-control
or cohort studies in English language. Second, the studies
needed to examine fish consumption as a risk factor for
bladder cancer. Last, each study should provide risk esti-
mate together with its corresponding 95% confidence
interval (CI) adjusted for at least age, sex and smoking
(or sufficient information to calculate it). We also
included the articles evaluating the risk of urinary tract
cancer with fish consumption, for bladder cancer
accounts for the overwhelming majority of tumors, and
the renal pelvis and ureter are covered by the same
urothelium. The term bladder cancer was used as a syno-
nym for these neoplasms.
The process of study selection was shown in Figure 1.
Seventeen potentially relevant studies were identified by
searching PubMed and references of retrieved articles or
reviews [3,7-22]. Three studies were excluded because
one reported only odds ratio (OR) but no 95% CI [8], and
two presented the ORs for meat and fish consumption
together [11,13]. Thus, a total of 14 studies were included
in this meta-analysis.
2.3 Data extraction
The following data were extracted independently by two
authors from each study: the name of the first author, year
of publication, the country in which the study was con-
ducted, study design, study period, sample size, exposure
of fish consumption, risk estimates with corresponding
95% CIs for highest vs lowest level of fish consumption,
covariates controlled for in the analysis and exposure
assessment. Because bladder cancer is a rare disease, OR
can be interpreted as RR. For simplicity, we report all
results as RR.
2.4 Statistical analysis
We estimated a pooled RR with 95% CI based on ran-
dom-effects models, which incorporates both within and
between-study variability [23]. One study reported sex-
stratified RRs, we calculated the overall sex-adjusted RR
by combining the two estimates with the method of
Mantel and Haenszel [24]. Heterogeneity was assessed
using Q-test [23] and I
2 score [25], and statistical signifi-
cance was considered while P < 0.05. A sensitivity analy-
sis was conducted to test the impact of each study on
the pooled estimates by removing each study from the
meta-analysis separately. Publication bias was assessed
through visual inspection of funnel plots, and tests of
Begg [26]. We performed meta-regression analysis to
explore the influence of study design, geographical
region and publication years in the heterogeneity. All
statistical analyses were conducted using Stata (Stata-
Corp, College Station, Texas).
3. Results
Table 1 presents the basic characteristics of each study
included in our meta-analysis. There were 5 cohorts and
9 case-control studies (3 population-based and 6 hospi-
tal-based case-control studies). Seven studies were con-
ducted in Europe, 3 in US/Canada, 3 in Japan, and the
remaining one in Uruguay. Most studies have reported
non-significant associations, and the risks were signifi-
cantly decreased in 2 studies.
Risk estimates for highest vs lowest level of fish con-
sumption are shown in Figure 2. The summary RR of all
studies, using a random effects model, did not show that
fish consumption was significantly associated with
decreased risk of bladder cancer (RR, 0.86; 95% CI, 0.61-
1.12). There was statistically significant heterogeneity
across the studies (P < 0.001, I
2 = 85.4%). Begg’sf u n n e l
plot indicated that there was no significant publication
bias (Figure 3, P = 0.101). A sensitivity analysis in which
one study at a time removed was performed to evaluate
the stability of the results. The summary RR ranged from
0.83 (95% CI, 0.57-1.10) (when excluding the study by
Riboli et al [10]) to 0.91 (95% CI, 0.63-1.20) (when
excluding the study by sakauchi et al [17]), indicating the
stability of results.
To explore the source of heterogeneity, we next pooled
the RR estimates by study design, geographical region,
and exposure assessment (Table 2). The summary RRs
neither from cohort studies (RR, 0.84; 95% CI, 0.42-1.26)
nor from all case-control studies (RR, 0.87; 95% CI, 0.54-
1 . 2 1 )s h o w e dt h a tf i s hi n t a k ew a sr e l a t e dt od e c r e a s e d
bladder cancer risk. When we separated the population-
based case-control studies from their hospital-based
case-control studies, we found no apparent difference
between hospital-based case-control studies (RR, 0.88;
95% CI, 0.40-1.36) and population-based case-control
studies (RR, 0.83; 95% CI, 0.63-1.03). In addition, the RR
estimates showed fish consumption was consistently
associated with a decreased but non-significant risk of
bladder cancer when separately analyzed by geographical
region and exposure assessment. We also performed sub-
g r o u pa n a l y s i sb yc a s es a m p l es i z e .T h es t u d i e sw h i c h
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defined as “large”, and those with less than 200 cases
were considered as “small”.W ef o u n dam a r g i n a l l y
decreased risk of bladder cancer for studies of small case
sample size (RR, 0.68; 95% CI, 0.34-1.02). However, the
combined RR for studies with larger case sample size,
which provide more reliable results, supported that fish
intake was not related to risk of bladder cancer.
Meta-regression analysis was used to explore the influ-
ence of publication year, geographical region, study
design, case sample size and exposure assessment in the
heterogeneity. However, none of them was identified as
a possible source of heterogeneity among all the
included studies.
4. Discussion
Diet is considered to play a very important role in pre-
venting cancer. Fish is an important aspect of diet that
has been linked favorably or unfavorably to the risk of
several cancers. On the one hand, there are serious
Figure 1 Process of study selection for fish consumption and risk of bladder cancer.
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Page 3 of 7Table 1 Study characteristics of published cohort and case-control studies on fish intake and bladder cancer
Authors and
publication
year
Study
design
Country Study
period
Cases/
subjects
Fish consumption RR (95%
CI)
Variables of adjustment Assessment
Steineck et al.
1988
Cohort Sweden 1968-1982 80/
16477
Ever vs ever 1.3 (0.8-2.2) Age, sex and smoking Questionnaire
Steineck et al.
1990
PCC Sweden 1985-1987 326/719 Weekly vs more
seldom
1.1 (0.7-1.8) Age, sex and smoking Questionnaire
Riboli et al.
1991
HCC Spain 1985-1986 432/
1221
The highest vs the
first quartile
1.26 (0.86-
1.84)
Age, smoking and total calories Interview
Chyou et al.
1993
Cohort USA 1965-1991 96/7090 ≥ 5 times/wk vs ≤
once/wk
0.67 (0.26-
1.67)
Age, smoking Both
techniques
Fernandez et al.
1999
HCC Italy 1983-1996 431/
7990
≥ 2 servings/wk vs
< 1 serving/wk
1.4 (1.0-1.8) Age, sex, area of residence, education, smoking, alcohol consumption, and body
mass index
Interview
Nagano et al.
2000
Cohort Japan 1979-1993 114/
38540
≥ 5 times/wk vs ≤
once/wk
1.31 (0.75-
2.25)
Age, gender, radiation dose, smoking status, education level, body mass index and
calendar time
Questionnaire
Wakai et al.
2000
HCC Japan 1996-1999 297/592 The highest vs the
first quartile
0.86 (0.54-
1.38)
Age, sex, smoking and occupational history as a cook. Interview
Balbi et al
2001
HCC Uruguay 1998-1999 144/720 The highest vs the
first tertile
0.82 (0.49-
1.36)
Age, sex, residence, urban/rural status, education, body mass index, tobacco
smoking, ‘mate’ drinking, and total calories.
Interview
Sakauchi et al.
2005
Cohort Japan 1988-1997 115/
65184
Almost every day
vs 1-2 times/month
0.36 (0.18-
0.72)
Age, sex and smoking Questionnaire
Baena et al.
2006
HCC Spain Not
mentioned
74/163 ≥ 3 times/wk vs
never
0.13 (0.05-
0.33)
Age, smoking, water intake Interview
Holick et al.
2006
Cohort US 1986-2002 736/
173229
≥ 1 serving/day vs
1-3 serving/month
Men 0.71
(0.48-1.04)
Women
1.33 (0.74-
2.40)
Age, sex, total caloric intake, pack-years of cigarette smoking, and current smoking Questionnaire
Garcı’a-Closas et
al.
2007
HCC Spain 1998-2001 873/
1785
The highest vs the
first quintile
0.9 (0.6-1.2) Age, gender, region, smoking status, duration of smoking and quintiles of fruit and
vegetable intake
Interview
Hu et al.
2008
PCC Canada 1994-1997 1029/
6068
The highest vs the
first tertile
0.8 (0.6-1.1) Age, province, education, body mass index, sex, alcohol, smoking, total of vegetable
and fruit intake, and total energy intake
Questionnaire
Brinkman et al.
2011
PCC Belgium 1999-2004 200/486 The highest vs the
first tertile
0.77 (0.47-
1.27)
Sex, age, smoking status, number of cigarettes smoked per day, number of years
smoking, occupational exposure to PAHs or aromatic amines and energy intake.
Questionnaire
PCC: population-base case-control study, HCC: hospital-base case-control study.
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7concerns about mercury and other environmental impu-
rities that accumulated in fish. On the other hand, fish is
regarded as a terrific source of polyunsaturated fatty
acids. This present study is the first meta-analysis sum-
marizing the evidence to date regarding the association
between fish consumption and bladder cancer risk. Over-
all, the summary RR for all of the studies suggested no
significant association between fish consumption and the
bladder cancer risk. There was a significant heterogeneity
among the studies. However, the results were also non-
significant when the case-control or cohort studies were
evaluated individually, or in subgroup analysis by geogra-
phical regions, case sample size and exposure assessment.
Moreover, we did not identify any potential sources of
heterogeneity using meta-regression analysis.
We noted that the associations between fish intake and
bladder cancer risk were negative in all studies published
after 2000, while the RRs for studies before 2000 tend to
be positive (Table 1). This might be explained in part by
Figure 2 Forest plots showing risk estimates from case-control and cohort studies estimating the association between fish
consumption and risk of bladder cancer.
Figure 3 Funnel plot of fish consumption and bladder cancer
risk.
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y e a r s .C i g a r e t t es m o k i n gi so n eo ft h em o s ti m p o r t a n t
risk factors for bladder cancer, so it is possible that smok-
ing may confound the fish-bladder cancer association if
n o tp r o p e r l yc o n t r o l l e df o r ,w h i c hm a yb ep a r t i c u l a r l y
true in older studies, leading to spurious positive associa-
tions between fish intake and bladder cancer risk. How-
ever, we could not provide the separate meta-analyses for
nonsmokers and smokers because of the few studies
available.
The association between fish intake and bladder cancer
is biologically plausible. Fish and fish oil are a rich source
of long-chain, n-3 polyunsaturated fatty acids (PUFA),
eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA). The n-3 fatty acids is suggested to reduce cancer
risk via several potential mechanisms, including modula-
tion of eicosanoid production and inflammation, angio-
genesis, proliferation, susceptibility for apoptosis, and
estrogen signaling, which are variables that are key dri-
vers in cancer progression [27]. Using animal models,
researchers have found that supplementing the diet of
tumor-bearing mice or rats with purified n-3 fatty acids
has slowed the growth of various types of cancers
[28-30]. In addition, intake of oils containing EPA or
DHA has also been shown to suppress cancer growth in
animal studies [31-33]. However, no data regarding to
the effects of fish ingredients on bladder cancer has been
published.
The present study has important limitations which
should be considered when interpreting our results. First,
fish consumption includes fatty fish, which are much
higher in the fatty acids, as well as fish that are lower in
marine fatty acids, and many studies have also reported
increased cancer risks associated with consumption of
salted fish. However, we only assessed total fish con-
sumption because most of these studies were not primar-
ily designed to investigate the effect of fish consumption
on bladder cancer risk, and did not specify what type of
fish was consumed, providing one explanation for the
heterogeneity of the study. Second, only articles pub-
lished in the English language were included, and we did
not search for unpublished studies or original data,
although no publication bias was indicated visually or in
formal statistical testing. Third, the classification of expo-
sure varied considerably across the included studies, and
the different amount of fish consumption may contribute
to the heterogeneity among studies in the analysis of the
highest versus the lowest intake categories.
Conslusion
In conclusion, in this meta-analysis of 5 cohorts and 9
case-control studies, we did not found fish consumption
was associated with reduced risk of bladder cancer.
Given the small number of cohort studies included in
this meta-analysis, further prospective cohort studies
with larger sample size, well-controlled confounding fac-
tors, and more accurate assessment of fish consumption
are needed to affirm the effect of fish on bladder cancer.
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